A critical discovery in cancer investigation is occurring with the use of mini-antibodies to re-engage mutated p53. This vital tumor inhibitor protein is frequently lost in various types of cancer, causing uncontrolled https://bookmarksparkle.com/story22091409/mini-antibodies-reactivate-the-p53-protein-a-promising-hope-for-cancer-management